Early cancer detection in blood
Amadix is a pioneering biotechnology research company dedicated to transforming early cancer detection through innovative liquid biopsy technologies. With a focus on developing cutting-edge diagnostic tests, Amadix is committed to extending and improving lives by detecting tumors years before symptoms appear.
Located at 2 Acera de Recoletos St, 1B, Valladolid, Castilla y León 47004, ES, Amadix specializes in personalized medicine and the identification of key biomarkers. Through its groundbreaking research, Amadix is at the forefront of advancements in cancer diagnostics, offering hope for earlier and more effective treatment interventions. The company’s mission is to make a significant impact on global health through early and accurate cancer detection.
Amadix continues to innovate and expand its capabilities in molecular diagnostics, contributing to a future where cancer can be detected and treated at its earliest stages. Our team is continuously working to update our information and provide even greater detail about Amadix's offerings. We invite the manager of Amadix to create a customized and exclusive company showcase and product listing on our platform to further highlight their groundbreaking work.
Amadix es una empresa pionera en investigación biotecnológica dedicada a transformar la detección temprana del cáncer a través de innovadoras tecnologías de biopsia líquida. Centrada en el desarrollo de pruebas diagnósticas de vanguardia, Amadix se compromete a extender y mejorar vidas detectando tumores años antes de que aparezcan los síntomas.
Ubicada en 2 Acera de Recoletos St, 1B, Valladolid, Castilla y León 47004, ES, Amadix se especializa en medicina personalizada y en la identificación de biomarcadores clave. A través de su innovadora investigación, Amadix está a la vanguardia de los avances en el diagnóstico del cáncer, ofreciendo esperanza para intervenciones de tratamiento más tempranas y eficaces. La misión de la empresa es tener un impacto significativo en la salud mundial a través de la detección temprana y precisa del cáncer.
Amadix continúa innovando y expandiendo sus capacidades en el diagnóstico molecular, contribuyendo a un futuro en el que el cáncer pueda detectarse y tratarse en sus primeras etapas. Nuestro equipo está trabajando continuamente para actualizar nuestra información y proporcionar aún más detalles sobre las ofertas de Amadix. Invitamos al gerente de Amadix a crear una presentación de empresa y un listado de productos personalizados y exclusivos en nuestra plataforma para destacar aún más su innovador trabajo.
Compare Amadix with 3 companies in Biotechnology-Research
| Comparison Field |
AmadixMain Company |
PentaBaseView Profile |
Leibniz-Institut für...View Profile |
Target ALSView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2006 | 1952 | 2013 |
|
Company Size
|
— | 51-200 | 51-200 | 2-10 |
|
City
|
Valladolid, Castilla y León | Odense, Syddanmark | Dortmund, North Rhine-Westphalia | New York City, New York |
|
Country
|
Spain | Denmark | Germany | United States |
|
Skills & Keywords
Comparing with main company
|
11 Total Skills
Biotechnology Research
Liquid Biopsy
Cancer Detection
Molecular Diagnostics
Personalized Medicine
Biomarkers
Cancer Diagnostics
Biotechnology
Blood test
Personalized medicine
Innovation
|
4 Total
4 Unique
Unique Skills:
Cancer detection
COVID-19 Test
PCR
Viral Detection
|
16 Total
16 Unique
Unique Skills:
Analytics
Assay development
Diagnostics
Imaging
Lipidomics
Metabolomics
+10
|
12 Total
12 Unique
Unique Skills:
Clinical Trials
Collaboration
Consortia
Drug Development
Fellowships
Funding
+6
|
Other organizations in the same industry
This company is also known as